Ignite Creation Date:
2024-05-06 @ 12:16 AM
Last Modification Date:
2024-10-26 @ 10:47 AM
Study NCT ID:
NCT01531361
Status:
COMPLETED
Last Update Posted:
2021-01-22
First Post:
2012-02-06
Brief Title:
Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Refractory Malignant Neoplasm |
| Advanced Malignant Neoplasm |
| BRAF Gene Mutation |
| Metastatic Malignant Neoplasm |
| Recurrent Malignant Neoplasm |
Keywords: